Topics

Arcus Biosciences and Strata Oncology Announce Clinical Development Collaboration for Anti-PD-1 Antibody AB122

07:30 EDT 2 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
- Leverages Strata Oncology’s Proprietary Biomarker Technology to Stratify Patients - Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, a...

Other Sources for this Article

For Arcus Biosciences

Katherine Bock
(415) 533-5670
kbock@arcusbio.com

Nicole Arndt
(510) 284-4728
narndt@arcusbio.com

For Strata Oncology

Terri Clevenger
(203) 856-4326
Terri.clevenger@icrinc.com

NEXT ARTICLE

More From BioPortfolio on "Arcus Biosciences and Strata Oncology Announce Clinical Development Collaboration for Anti-PD-1 Antibody AB122"

Quick Search

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...